Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 of intrathecal hyperbaric ropivacaine with intrathecal dexmedetomidine for cesarean section
ChiCTR2000038406Phase 4Recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine and dexmedetomidine in caesarean delivery (C-section) (10 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: Sensory block level. Started Sep 2020; status: recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on ChiCTR2000038406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038406.